BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6105177)

  • 1. Identification in human urine of delta 9-tetrahydrocannabinol-11-oic acid glucuronide: a tetrahydrocannabinol metabolite.
    Williams PL; Moffat AC
    J Pharm Pharmacol; 1980 Jul; 32(7):445-8. PubMed ID: 6105177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of liquid chromatography with ultraviolet detection and gas chromatography with electron-capture detection for the determination of delta 9-tetrahydrocannabinol-11-oic acid in urine.
    Karlsson L; Roos C
    J Chromatogr; 1984 Mar; 306():183-9. PubMed ID: 6325483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More acidic metabolites of delta1-tetrahydrocannabinol isolated from rabbit urine.
    Nordqvist M; Agurell S; Rydberg M; Falk L; Ryman T
    J Pharm Pharmacol; 1979 Apr; 31(4):238-43. PubMed ID: 36463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Confirmation of cannabis use by the analysis of delta 9-tetrahydrocannabinol metabolites in blood and urine by combined HPLC and RIA.
    Law B; Mason PA; Moffat AC; King LJ
    J Anal Toxicol; 1984; 8(1):19-22. PubMed ID: 6323852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the major metabolite of delta 9-tetrahydrocannabinol in urine. V. Cross-reactivity of selected compounds in a radioimmunoassay.
    Jones AB; ElSohly HN; ElSohly MA
    J Anal Toxicol; 1984; 8(6):252-4. PubMed ID: 6097766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel 125I radioimmunoassay for the analysis of delta 9-tetrahydrocannabinol and its metabolites in human body fluids.
    Law B; Mason PA; Moffat AC; King LJ
    J Anal Toxicol; 1984; 8(1):14-8. PubMed ID: 6323851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion half-life of delta 1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking.
    Johansson E; Halldin MM
    J Anal Toxicol; 1989; 13(4):218-23. PubMed ID: 2550702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of phase II metabolism of 11-hydroxy-Δ-9-tetrahydrocannabinol and metabolite verification by chemical synthesis of 11-hydroxy-Δ-9-tetrahydrocannabinol-glucuronide.
    Hassenberg C; Clausen F; Hoffmann G; Studer A; Schürenkamp J
    Int J Legal Med; 2020 Nov; 134(6):2105-2119. PubMed ID: 32808050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forensic aspects of the metabolism and excretion of cannabinoids following oral ingestion of cannabis resin.
    Law B; Mason PA; Moffat AC; Gleadle RI; King LJ
    J Pharm Pharmacol; 1984 May; 36(5):289-94. PubMed ID: 6145762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the major metabolite of delta 9-tetrahydrocannabinol in urine. IV. A comparison of five methods.
    Jones AB; ElSohly HN; Arafat ES; ElSohly MA
    J Anal Toxicol; 1984; 8(6):249-51. PubMed ID: 6097765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined high-performance liquid chromatography and radioimmunoassay method for the analysis of delta 9- tetrahydrocannabinol and its metabolites in plasma and urine.
    Moffat AC; Williams PL; King LJ
    NIDA Res Monogr; 1982; 42():56-68. PubMed ID: 6294526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Routine detection of the THC metabolite 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid in forensic practice].
    Hanke M; Megges G
    Z Rechtsmed; 1983; 90(2):105-8. PubMed ID: 6312709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Δ9-tetrahydrocannabinol and its major metabolite Δ9-tetrahydrocannabinol-11-oic acid as 15-lipoxygenase inhibitors.
    Takeda S; Jiang R; Aramaki H; Imoto M; Toda A; Eyanagi R; Amamoto T; Yamamoto I; Watanabe K
    J Pharm Sci; 2011 Mar; 100(3):1206-11. PubMed ID: 20891010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reactivity of selected compounds in the Abbott TDx cannabinoid assay.
    ElSohly MA; Jones AB; ElSohly HN
    J Anal Toxicol; 1990; 14(5):277-9. PubMed ID: 2175818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative determination of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid in urine by HPLC.
    Posey BL; Kimble SN
    J Anal Toxicol; 1984; 8(5):234-8. PubMed ID: 6094916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marijuana metabolites in urine of man. X. Identification of marijuana use by detection of delta 9-tetrahydrocannabinol-11-oic acid using thin-layer chromatography.
    Kanter SL; Hollister LE; Musumeci M
    J Chromatogr; 1982 Jan; 234(1):201-8. PubMed ID: 6276425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confirmation of cannabis use. II. Determination of tetrahydrocannabinol metabolites in urine and plasma by HPLC with ECD.
    Nakahara Y; Sekine H; Cook CE
    J Anal Toxicol; 1989; 13(1):22-4. PubMed ID: 2540383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct injection of urine on a high-performance liquid chromatographic column-switching system for determination of delta 9-tetrahydrocannabinol-11-oic acid with both ultraviolet and electrochemical detection.
    Karlsson L
    J Chromatogr; 1987 Jul; 417(2):309-17. PubMed ID: 2821045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human urinary excretion profile after smoking and oral administration of [14C]delta 1-tetrahydrocannabinol.
    Johansson E; Gillespie HK; Halldin MM
    J Anal Toxicol; 1990; 14(3):176-80. PubMed ID: 2165199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment of urine samples for the analysis of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid using solid-phase extraction.
    Parry RC; Nolan L; Shirey RE; Wachob GD; Gisch DJ
    J Anal Toxicol; 1990; 14(1):39-44. PubMed ID: 2156110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.